Skip to main content
. 2016 Mar 18;95(11):e3134. doi: 10.1097/MD.0000000000003134

FIGURE 2.

FIGURE 2

(A) Meta-analysis of included studies with an analysis of the ORR of PD-1 and PD-L1 inhibitors for patients with advanced melanoma (random effects model). (B) Meta-analysis of included RCTs with a comparison of the ORR between PD-1 inhibitors and chemotherapy in patients with advanced melanoma (fixed-effects model).